Macroscopic Portal Vein Thrombosis in HCC Patients

被引:25
作者
Akkiz, Hikmet [1 ]
Carr, Brian I. [2 ]
Kuran, Sedef [1 ]
Karaogullarindan, Umit [1 ]
Uskudar, Oguz [1 ]
Tokmak, Salih [1 ]
Arslan, Burcu [1 ]
Doran, Figen [1 ]
Balli, Huseyin Tugsan [1 ]
Ulku, Abdulalh [1 ]
Akcam, Tolga Atilgan [1 ]
Bahceci, Halil Ibrahim [3 ]
Polat, Kamil Yalcin [4 ]
Ormeci, Necati [5 ]
Simsek, Halis [6 ]
Sonsuz, Abdullah [7 ]
Demir, Ali [8 ]
Altintas, Engin [9 ]
Demir, Mehmet [10 ]
Yalcin, Kendal [11 ]
Ekinci, Nazim [11 ]
Ozakyol, Aysegul Harmanci [12 ]
Yucesoy, Mehmet [13 ]
Uygun, Ahmet [14 ]
Guerra, Vito [15 ]
Delik, Anil [1 ]
Tokat, Yaman [16 ]
Yilmaz, Sezai [17 ]
Bektas, Ahmet [18 ]
Kilic, Murat [19 ]
机构
[1] Cukurova Univ, Gastroenterol Dept, Adana, Turkey
[2] Dokuz Eylul Univ, Izmir Biomed & Genome Inst, Izmir, Turkey
[3] Firat Univ, Elazig, Turkey
[4] Istanbul Mem Hosp, Istanbul, Turkey
[5] Ankara Univ, Ankara, Turkey
[6] Hacettepe Univ, Ankara, Turkey
[7] Istanbul Cerrahpasa Univ, Istanbul, Turkey
[8] Konya Necmettin Erbakan Univ, Konya, Turkey
[9] Mersin Univ, Mersin, Turkey
[10] Hatay Mustafa Kemal Univ, Antakya, Turkey
[11] Dicle Univ, Diyarbakir, Turkey
[12] Eskisehir Osmangazi Univ, Eskisehir, Turkey
[13] Erciyes Univ, Kayseri, Turkey
[14] Haydarpasa Sultan Abdulhamid Egitim Arastirma Hos, Istanbul, Turkey
[15] IRCCS Saverio de Bellis, Natl Inst Digest Dis, Trials Ctr, Bari, Italy
[16] Florence Nightingale Hosp, Istanbul, Turkey
[17] Inonu Univ, Malatya, Turkey
[18] Ondokuz Mayis Univ, Kurupelit, Turkey
[19] Izmir Kent Hosp, Izmir, Turkey
关键词
GAMMA-CARBOXY PROTHROMBIN; UNRESECTABLE HEPATOCELLULAR-CARCINOMA; AUTOLOGOUS GROWTH-FACTOR; COMPUTED-TOMOGRAPHY; PROGNOSTIC-FACTORS; ALPHA-FETOPROTEIN; VENOUS INVASION; TUMOR; SURVIVAL; ULTRASOUND;
D O I
10.1155/2018/3120185
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Macroscopic portal vein invasion (PVT) by hepatocellular carcinoma (HCC) in the liver is one of the most important negative prognostic factors for HCC patients. The characteristics of a large cohort of such patients were examined. We found that the percent of patients with PVT significantly increased with increasing maximum tumor diameter (MTD), from 13.7% with tumors of MTD <5cm to 56.4% with tumors of MTD >10cm. There were similar numbers of HCC patients with very large tumors with and without PVT. Thus, MTD alone was insufficient to explain the presence of PVT, as were high AFP levels, since less than 50% of high AFP patients had PVT. However, the percent of patients with PVT was also found to significantly increase with increasing blood alpha-fetoprotein (AFP) levels and tumormultifocality. A logistic regressionmodel that included these 3 factors together showed an odds ratio of 17.9 for the combination of MTD >5.0cm plus tumor multifocality plus elevated AFP, compared to low levels of these 3 parameters. The presence or absence of macroscopic PVT may therefore represent different HCC aggressiveness phenotypes, as judged by a significant increase in tumor multifocality and AFP levels in the PVT positive patients. Factors in addition to MTD and AFP must also contribute to PVT development.
引用
收藏
页数:8
相关论文
共 42 条
[1]   Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies [J].
Bruix, Jordi ;
Cheng, Ann-Lii ;
Meinhardt, Gerold ;
Nakajima, Keiko ;
De Sanctis, Yoriko ;
Llovet, Josep .
JOURNAL OF HEPATOLOGY, 2017, 67 (05) :999-1008
[2]   Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients [J].
Carr, Brian I. ;
Guerra, Vito .
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2017, 32 (04) :E391-E396
[3]   Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis [J].
Carr, Brian I. ;
Guerra, Vito .
DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (03) :937-947
[4]  
Carr BI, 2010, HEPATO-GASTROENTEROL, V57, P1375
[5]   Differential Effects of Vitamin K1 on AFP and DCP Levels in Patients with Unresectable HCC and in HCC Cell Lines [J].
Carr, Brian I. ;
Wang, Ziqiu ;
Wang, Meifung ;
Wei, Gang .
DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (06) :1876-1883
[6]   Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study [J].
Carr, Brian I. ;
Pancoska, Petr ;
Branch, Robert A. .
HEPATOLOGY INTERNATIONAL, 2010, 4 (01) :396-405
[7]   Survival benefits of intra-arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis [J].
Cheong, JY ;
Lee, KM ;
Cho, SW ;
Won, JH ;
Kim, JK ;
Wang, HJ ;
Hahm, KB ;
Kim, JH .
HEPATOLOGY RESEARCH, 2005, 32 (02) :127-133
[8]  
DESIO I, 1995, J GASTROEN HEPATOL, V10, P662
[9]   PERCUTANEOUS BIOPSY OF PORTAL-VEIN THROMBUS - A NEW STAGING TECHNIQUE FOR HEPATOCELLULAR-CARCINOMA [J].
DODD, GD ;
CARR, BI .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1993, 161 (02) :229-233
[10]   Selective internal radiation therapy compared with sorafenib for hepatocellular carcinoma with portal vein thrombosis [J].
Edeline, Julien ;
Crouzet, Laurence ;
Campillo-Gimenez, Boris ;
Rolland, Yan ;
Pracht, Marc ;
Guillygomarc'h, Anne ;
Boudjema, Karim ;
Lenoir, Laurence ;
Adhoute, Xavier ;
Rohou, Tanguy ;
Boucher, Eveline ;
Clement, Bruno ;
Blanc, Jean-Frederic ;
Garin, Etienne .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (04) :635-643